Expressions of tissue factor and tissue factor pathway inhibitor in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 29, Issue 6, 2009, Pages 697-700

  Hao, Jinjin ^a   Li, Weiming ^a   Zou, Ping ^a   Li, Quan ^a   Xia, Linghui ^a   You, Yong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Graft versus host disease; Hematopoietic stem cell transplantation; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

LIPOPROTEIN; LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ACUTE DISEASE; ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; BLOOD; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; MALE; METABOLISM; MIDDLE AGED; PROGNOSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; LIPOPROTEINS; MALE; MIDDLE AGED; PROGNOSIS; THROMBOPLASTIN; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 77149173763     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-009-0604-4     Document Type: Article

References (25)

1. K. Hattori T. Hirano Yamakawa, et al. 1998 Differential effects of anti-Fas ligand and anti TNF-A antibodies on acute graft vs host disease pathologies Blood 91 11 4051 4055 1:CAS:528:DyaK1cXjsV2isLs%3D 9596649
2. A. Falanga A. Vignoli M. Marchetti, et al. 2003 Defibrotide reduces procoagulant activity and increases fibronolytic properties of endothelial cells Leukemia 17 8 1636 1642 10.1038/sj.leu.2403004 1:CAS:528:DC%2BD3sXlslOisbY%3D 12886253 (Pubitemid 36986967)
3. E. Camerer A.B. Kolsto H. Prydz 1996 Cell biology of tissue factor, the principal initiator of blood coagulation Thromb Res 81 1 1 41 10.1016/0049-3848(95)00209-X 1:CAS:528:DyaK28XivFenug%3D%3D 8747518 (Pubitemid 26027721)
4. R.T. Pyo Y. Sato N. Mackman, et al. 2004 Mice deficient in tissue factor demonstrate attenuated intimal hyperplasia in response to vascular injury and decreased smooth muscle cell migration Thromb Haemost 92 3 451 458 1:CAS:528:DC%2BD2cXnvFyht7g%3D 15351840
5. P. Carmeliet N. Mackman L. Moons, et al. 1996 Role of tissue factor in embryonic blood vessel development Nature 383 6595 73 75 10.1038/383073a0 1:CAS:528:DyaK28XlsV2jsbo%3D 8779717 (Pubitemid 26296462)
6. J. Rak C. Milsom L. May, et al. 2006 Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy Semin Thromb Hemost 32 1 54 70 10.1055/s-2006-933341 1:CAS:528:DC%2BD28XisFajs78%3D 16479463
7. A. Janin C. Deschaumes M. Daneshpouy, et al. 2002 CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications Blood 99 8 2940 2947 10.1182/blood.V99.8.2940 1:CAS:528:DC%2BD38XivV2js78%3D 11929785 (Pubitemid 34525384)
8. Zhang ZL, Shen T. Blood disease diagnosis and efficacy standards (the third version). Beijing: Science Press, 1999,269-276
9. E.D. Thomas R. Storb R.A. Clift, et al. 1975 Bone marrow transplantation New Engl J Med 292 4 832 8434 1:STN:280:DyaE2M7gtVakuw%3D%3D 234595
10. A. Sureda N. Schmitz 2003 Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies Ann Hematol 82 1 1 13 1:STN:280:DC%2BD3s%2FmtlSntg%3D%3D 12574957 (Pubitemid 36700963)
11. M. Bleakley S.R. Riddell 2004 Molecules and mechanisms of the graft-versus-leukaemia effect Nat Rev Cancer 4 5 371 380 10.1038/nrc1365 1:CAS:528:DC%2BD2cXjsFSksr8%3D 15122208
12. A. Naji F. Deschaseaux E. Racadot, et al. 2005 Induction of tissue factor expression on human umbilical vein endothelial cells by cell-specific HLA class I antibody Transplant Proc 37 6 2892 2893 10.1016/j.transproceed.2005.08.001 1:CAS:528:DC%2BD2MXhtVegtLvK 16182846 (Pubitemid 41354770)
13. X. Ge A. Karrar B.G. Ericzon, et al. 2005 Antibodies to liver sinusoidal endothelial cells modulate immune responses in liver transplantation Transplant Proc 37 8 3335 3337 10.1016/j.transproceed.2005.09.001 1:CAS:528: DC%2BD2MXht1aqtrvL 16298589 (Pubitemid 41659881)
14. C.T. Esmon K. Fukudome T. Mather, et al. 1999 Inflammation, sepsis, and coagulation Haematologica 84 3 254 259 1:CAS:528:DC%2BD3cXlslSksw%3D%3D 10189392
15. C.T. Esmon 2005 The interactions between inflammation and coagulation Br J Haematol 131 4 417 430 10.1111/j.1365-2141.2005.05753.x 1:CAS:528: DC%2BD2MXhtlCisbnN 16281932 (Pubitemid 43899639)
16. R.J. Shebuski K.S. Kilgore 2002 Role of Inflammatory mediators in thrombogenesis Pharmacol Exp Ther 300 3 729 735 10.1124/jpet.300.3.729 1:CAS:528:DC%2BD38XitVemsbs%3D (Pubitemid 34164973)
17. L. Shama E. Melis M.J. Hickey, et al. 2004 The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia Am J Pathol 165 1 331 403
18. C.A. Spek 2004 Tissue factor from just one of the coagulation factor to a major player in physiology Blood Coagul Fibrinolysis 15 Suppl1 S3 10 10.1097/00001721-200405001-00002 1:CAS:528:DC%2BD2cXmt1Ggu7c%3D 15166927 (Pubitemid 38757069)
19. T. Imamura 2004 Tissue factor expression at the site of inflammation: a cross-talk between inflammation and the blood coagulation system Rinsho Byori 52 4 342 349 1:CAS:528:DC%2BD2cXjvVCnt7o%3D 15164603
20. E. Schmid T.H. Muller R.M. Budzinski, et al. 1995 Lymphocyte adhesion to human endothelial cells induces tissue factor expression via a juxtacrine pathway Thromb Haemost 73 3 421 428 1:CAS:528:DyaK2MXksVersbs%3D 7545320
21. J. Friedl M. Puhlmann D.L. Bartlett, et al. 2002 Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF Blood 100 4 1334 1339 1:CAS:528:DC%2BD38Xmt12itb0%3D 12149215
22. M.M. Levy M.P. Fink J.C. Marshall, et al. 2003 2001 SCCM/ESICM/ACCP/ATS/ SI international sepsis definitions conference Crit Care Med 31 4 1250 1256 10.1097/01.CCM.0000050454.01978.3B 12682500 (Pubitemid 36444440)
23. S. Gando T. Kameue Y. Morimoto, et al. 2002 Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis Crit Care Med 30 8 1729 1734 10.1097/00003246-200208000-00009 1:CAS:528:DC%2BD38XmvFSns74%3D 12163784
24. P. Enkhbaatar K. Okajima K. Murakami, et al. 2000 Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide induced pulmonary vascular lung injury by inhibiting leukocyte activation Am J Respir Crit Care Med 162 5 1752 1759 1:STN:280:DC%2BD3M%2FkvFyqtQ%3D%3D 11069808
25. J.B. Hansen B. Svensson R. Olsen, et al. 2000 Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro Thromb Haemost 83 6 937 943 1:CAS:528:DC%2BD3cXkslOhurc%3D 10896252